Viral Conjunctivitis Therapeutics Market Pipeline Review, H2
2017
“Pharmaceutical and Healthcare disease pipeline guide Viral Conjunctivitis -
Pipeline Review, H2 2017, provides an overview of the Viral Conjunctivitis
(Ophthalmology) pipeline landscape.”
Summary
Pharmaceutical and Healthcare disease pipeline guide Viral Conjunctivitis - Pipeline Review, H2 2017,
provides an overview of the Viral Conjunctivitis (Ophthalmology) pipeline landscape.
Viral conjunctivitis, or pinkeye, is a common, self-limiting condition that is typically caused by adenovirus. Viral
conjunctivitis is highly contagious, usually for 10-12 days from onset as long as the eyes are red. Symptoms
include itchy eyes, tearing, redness, discharge and light sensitivity (with corneal involvement). Treatment
includes lubricants, vasoconstrictors and antihistamines.
Report Highlights
Pharmaceutical and Healthcare latest pipeline guide Viral Conjunctivitis - Pipeline Review, H2 2017, provides
comprehensive information on the therapeutics under development for Viral Conjunctivitis (Ophthalmology),
complete with analysis by stage of development, drug target, mechanism of action (MoA), route of
administration (RoA) and molecule type.
Browse Detail Report With TOC @
https://www.hexareports.com/report/viral-conjunctivitis-pipeline-review-h2-2017
Follow Us: